Cite
HARVARD Citation
Tschaidse, L. et al. (2023). Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European journal of endocrinology. 188 (1), p. . [Online].